Human Mannose-Binding Protein Functions As an Opsonin for Influenza a Viruses Kevan L

Total Page:16

File Type:pdf, Size:1020Kb

Human Mannose-Binding Protein Functions As an Opsonin for Influenza a Viruses Kevan L Human Mannose-binding Protein Functions as an Opsonin for Influenza A Viruses Kevan L. Hartshorn, * Kedamath Sastry, * Mitchell R. White, * E. Margot Anders, Michael Super,t R. Alan Ezekowitz,t and Alfred 1. Tauber* *Departments ofMedicine and Pathology, Boston University School ofMedicine and the Department ofMedicine, Boston City Hospital, Boston, Massachusetts 02118; Divisions oftHematology/Oncology and Infectious Diseases, Department ofPediatrics, Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; and 1Department ofMicrobiology, University ofMelbourne, Victoria, Australia Abstract sponses (1). However, frequent mutations occur in HA genes such that antigenic determinants of the virus are altered, ren- Influenza A viruses (IAVs) cause substantial morbidity and dering previously immune individuals susceptible to repeat in- mortality in yearly epidemics, which result from the ability of fection (2). These changes result in frequent epidemics and, the virus to alter the antigenicity of its envelope proteins. De- occasionally, pandemics of influenza. Although considerable spite the rapid replication of this virus and its ability to infect a morbidity and mortality may be associated with these out- wide variety of cell types, viremia is rare and the infection is breaks, there is heterogeneity in the clinical outcome for differ- generally limited to the upper respiratory tract. The preim- ent individuals infected with the same viral strain (3). For half mune host defense response against IAV is generally, there- a century it has been recognized that serum factors can inhibit fore, successful. We have previously provided (and summa- influenza hemagglutination (4). Recently, it has been estab- rized) evidence that neutrophils contribute to defense against lished that one class ofserum HA inhibitors, the "beta" inhibi- IAV, although neutrophil dysfunction and local tissue damage tors, are mannose-binding lectins (4, 5). Several strains ofIAV may be less salutory byproducts of this response. Here we pro- that have been selected on the basis of resistance to growth vide evidence that the serum lectin mannose-binding protein inhibition by beta inhibitors have been characterized (4, 5). In directly inhibits hemagglutinin activity and infectivity of sev- each case a specific mutation has been found in the resistant eral strains of IAV. In addition mannose-binding protein acts as strain (as compared with the parent, sensitive, strain), that an opsonin, enhancing neutrophil reactivity against IAV. Op- leads to loss of a specific glycosylation site. For two of the sonization of IAV by mannose-binding protein also protects the strains, the parent virus is known to have at this site a high neutrophil from IAV-induced dysfunction. These effects are mannose glycan attachment that lies in close proximity to the observed with physiologically relevant concentrations of man- cell attachment site ofthe HA. These findings suggest that beta nose-binding protein. Two different allelic forms of recombi- inhibitors of IAV act by binding to these high mannose struc- nant mannose-binding protein are found to have similar effects. tures, thus masking the cell attachment domain of the HA. We believe, on the basis of these data, that mannose-binding Two candidate serum lectins that may constitute beta inhib- protein alone and in conjunction with phagocytic cells is an itors are mannose-binding protein (MBP) and conglutinin (5- important constituent of natural immunity (i.e., preimmune de- 7). MBP and conglutinin are members ofa family ofmamma- fense) against IAV. (J. Clin. Invest. 1993.91:1414-1420.) Key lian serum lectins that have in common a Ca2+-dependent lec- words: neutrophils * hemagglutination * recombinant proteins* tin-binding domain at the COOH terminus and a collagenous mannose-binding protein , influenza A virus domain followed by a short area ofdisulfide bonds at the NH2 terminus (6). Both are present as multimeric structures in Introduction serum. Structurally both resemble C I q and are able to bind to Clq receptors through their collagen domain (6, 7). The product ofinfluenza A virus (IAV)' hemagglutinin (HA) This study has focused on the interaction of recombinant genes is expressed on the surface of infected cells and evokes MBPs with several strains of IAV. MBPs have been character- specific and long-lived humoral and cell-mediated immune re- ized in the serum ofmice, rats, rabbits, and humans (6, 7). The physiological role for these proteins appears to be in first line A preliminary report of some of the data presented in this paper has host defense and they may be considered as pattern-recogni- been published in abstract form ( 1991. J. Cell Biol. 115:361a.) tion molecules that function as ante-antibodies (8). MBPs are Address correspondence to Kevan L. Hartshorn, Department of acute-phase reactants (9, 10) that recognize a wide variety of Medicine, Boston University School ofMedicine, 80 East Concord St., disparate oligosaccharides that are present on the cell walls of Boston, MA 02118-2394. certain Gram-negative bacteria ( 1), fungal pathogens ( 12), Received for publication 13 August 1992 and in revisedform 12 and the envelope glycoprotein of human immunodeficiency November 1992. virus ( 13). There are at least two allelic variants ofMBP. In the vast majority ofindividuals there is one aberration in the colla- 1. Abbreviations used in this paper: HA, hemagglutinin; HAU, hemag- glutinin units; IAV, influenza A virus; MBP, mannose-binding protein; gen region at the eighth repeat as Gly-Gln-Gly is present rather PFU, plaque-forming units; rMBP, recombinant MBP. than Gly-X-Y-Gly. In 5-7% ofthe population Asp replaces Gly at the fifth collagen repeat, in addition to the irregularity ob- J. Clin. Invest. served more commonly ( 14). Homozygosity for this latter phe- © The American Society for Clinical Investigation, Inc. notype appears to segregate with low serum MBP levels, which 0021-9738/93/04/1414/07 $2.00 in turn have been associated with the phenotype of recurrent Volume 91, April 1993, 1414-1420 infections (14, 15). However, in recent studies both allelic 1414 Hartshorn, Sastry, White, Anders, Super, Ezekowitz, and Tauber forms of MBP have been shown to have similar functional Canberra, Australia) and the beta-inhibitor resistant mutant properties in vitro. One important difference is that the recom- (Mem7IH-BelN/BS) was developed by Dr. E. Margot Anders (Univer- binant MBP containing the Gly to Asp mutation at the fifth sity ofMelbourne, Parkville, Victoria, Australia). The H3N2/A/Bang- collagen repeat was not able to fix complement via the classical kok/ 1/79 (Bankok 79) strain was a gift of Dr. Robert Webster (St. Jude's Hospital, Memphis, TN). HA titers were determined by titra- pathway ( 14). In this paper we assess the interaction of both tion ofvirus samples in PBS followed by addition ofthoroughly washed forms of MBP with various influenza viral strains selected for human type 0 red blood cells. known differences in HA glycosylation. Incubation of MBPs with concentrated IAV stocks was carried out MBP-ligand complexes would be expected to encounter for 0.5 h at 370C in PBS with 1 mM Ca2" and Mg2", except in certain circulating cells, in particular neutrophils, which have been experiments where 2 mM EGTA or 10 mg/ml mannan (Sigma Chemi- shown to ingest bacteria opsonized with MBP ( 11). Neutro- cal Co.) were added, as indicated. For experiments with neutrophils, phils alone may play a role in the preimmune host defense aliquots of virus or MBP-treated virus were then added to cell suspen- against influenza ( 16, 17). We and others have characterized sion at a 1:40 vol/vol ratio. In describing these experiments, the final the interaction of human neutrophils with unopsonized IAV concentration of MBP in the neutrophil suspension is given. and found evidence that these cells are activated by IAV. In the Virus plaque formation was assessed on Madin-Darby canine kid- ney cells: duplicate confluent monolayers in six-well plates were ex- absence of antibody, neutrophils are stimulated by cell-free posed to virus preparations with orwithout MBP in 10-fold dilutions in virus to generate a pertussis toxin-insensitive respiratory burst serum-free CRCM-30 medium (Sigma Chemical Co.) for 1 h at 370C, response, characterized by hydrogen peroxide (H202), but no followed by washing twice in PBS. The monolayers were then overlaid superoxide (O°-) production ( 18, 19). Neutrophils are also re- with CRCM-30 media with 0.1% BSA, 0.4% agarose, 10 ,ug/ml trypsin, ported to specifically adhere to IAV-infected epithelial mono- and 10 ;g/ml DEAE-Dextran. The agarose solution was warmed until layers without mediation of antibody (20). After exposure to melting and allowed to cool to the touch, and then mixed with the other influenza viruses in vitro and in vivo, however, neutrophils and ingredients and layered over the cells before solidification. The mono- monocytes exhibit depressed responsiveness to various stimuli layers were then kept at 370C in a 5% CO2 incubator for 72 h, followed and depressed microbicidal activity against bacteria (21, 22). by removal ofthe agarose overlay. After staining with crystal violet, the In this report we demonstrate that both forms of recombinant plaques were counted by direct inspection and titers ofplaque-forming units (PFU)/ml calculated. Values given are mean PFU/ml for two MBP inhibit IAV HA activity and act as opsonins, enhancing wells. MDCK cells were obtained from the American Type Culture neutrophil responsiveness to the virus. Collection (Rockville, MD). Neutrophils from healthy volunteer donors were isolated to > 95% purity as previously described using dextran precipitation, followed by Methods a Ficoll-Hypaque gradient separation for removal ofmononuclear cells and hypotonic lysis to eliminate contaminating erythrocytes (21 ). Cell Reagents. FMLP, cytochalasin B, horseradish peroxidase type II, sco- viability was > 98% as determined by trypan blue staining, and cells poletin, SOD, cytochrome c, neuraminidase type X (protease activity were used within 5 h ofisolation.
Recommended publications
  • Opsonin-Dependent Stimulation of Bovine Neutrophil Oxidative Metabolism by Brucella Abortus Peter C
    Veterinary Microbiology and Preventive Medicine Veterinary Microbiology and Preventive Medicine Publications 2-1988 Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Peter C. Canning U.S. Department of Agriculture Billy L. Deyoe U.S. Department of Agriculture James A. Roth Iowa State University, [email protected] Follow this and additional works at: https://lib.dr.iastate.edu/vmpm_pubs Part of the Veterinary Microbiology and Immunobiology Commons, Veterinary Preventive Medicine, Epidemiology, and Public Health Commons, and the Veterinary Toxicology and Pharmacology Commons The ompc lete bibliographic information for this item can be found at https://lib.dr.iastate.edu/ vmpm_pubs/190. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Article is brought to you for free and open access by the Veterinary Microbiology and Preventive Medicine at Iowa State University Digital Repository. It has been accepted for inclusion in Veterinary Microbiology and Preventive Medicine Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Abstract Nonopsonized Brucella abortus and bacteria treated with fresh antiserum, heat-inactivated antiserum, or normal bovine serum were evaluated for their ability to stimulate production of superoxide anion and myeloperoxidasemediated iodination by neutrophils from cattle. Brucella abortus opsonized with fresh antiserum or beat-inactivated antiserum stimulated production of approximately 3 nmol of 0 2 -/106 neutrophils/30 min. Similarly treated bacteria also stimulated the binding of approximately 4.3 nmol of Nal/ 107 neutrophils/h to protein.
    [Show full text]
  • Complement Herbert L
    Host Defense 2011 Complement Herbert L. Mathews, Ph.D. COMPLEMENT Date: 4/11/11 Reading Assignment: Janeway’s Immunobiology, 7th Edition, pp. 54-55, 61-82, 406- 409, 514-515. Figures: (Unless otherwise noted) Janeway’s Immunobiology, 7th Edition, Murphy et al., Garland Publishing. KEY CONCEPTS AND LEARNING OBJECTIVES You will be able to describe the mechanism and consequences of the activation of the complement system. To attain the goals for these lectures you will be able to: a. List the components of the complement system. b. Describe the three activation pathways for complement. c. Explain the consequences of complement activation. d. Describe the consequence of complement deficiency. Page 1 Host Defense 2011 Complement Herbert L. Mathews, Ph.D. CONTENT SUMMARY Introduction Nomenclature Activation of Complement The classical pathway The mannan-binding lectin pathway The alternative pathway Biological Consequence of Complement Activation Cell lysis and viral neutralization Opsonization Clearance of Immune Complexes Inflammation Regulation of Complement Activation Human Complement Component Deficiencies Page 2 Host Defense 2011 Complement Herbert L. Mathews, Ph.D. Introduction The complement system is a group of more than 30 plasma and membrane proteins that play a critical role in host defense. When activated, complement components interact in a highly regulated fashion to generate products that: Recruit inflammatory cells (promoting inflammation). Opsonize microbial pathogens and immune complexes (facilitating antigen clearance). Kill microbial pathogens (via a lytic mechanism known as the membrane attack complex). Generate an inflammatory response. Complement activation takes place on antigenic surfaces. However, the activation of complement generates several soluble fragments that have important biologic activity.
    [Show full text]
  • Histamine Metabolism in Cells of the Allergic Response
    PLATELET RESPONSE TO IMMUNOLOGICAL INJURY. J.G. White, R.M. INDUCTION OF ABNORMAL IMMUNOPOIESIS BY PERSISTENT EMBRYONIC Condie, and G.H.R. Rao. Univ. of Minn. School of Med., Mpls., VIRAL INFECTION. T. Yamauchi, J.1,!. St. GE, Jr., H.L. Itartin, Minn . D.C. Heiner and P1.D. Cooper. UCLA Sch. Ned. Ifarbor Gen. Bosp. Platelets are susceptible to immunological destruction, and Univ. Ala. Pled. Ctr., Depts. Ped., Torr. and Birmingham. but the nature of the immune lesion has not been defined. Infection of 16-hour-old chicken embryos with mumps virus Biochemistry, physiology, freeze-etching and electron micro- produced an initial decrease of both plasmalIgM and IgG in scopy were used to detect antibody induced injury. Antiserum poults with delayed maturation of normal IgG synthesis. De- (AS) was raised in a horse by repeated I.M. injections of spite hypogammaglobulinemia, specific antiviral neutralizing glutaraldehyde fixed human platelets. Absorbtion with PPP re- antibody first appeared one week after disappearance of virus moved non-specific activity of AS. The AS caused release of from 7-day-old hatchling chicks. serotonin to a dilution of 1:10,000 without producing ultra- Intramuscular inoculation of 13-day-old chicks with heter- structural damage. AS stimulated aggregation in stirred C-PRP ologous erythrocytes elicited significantly (P<.01) lower to a dilution of 1:1000. Aggregates resembled those produced titers of agglutinins in embryonically-infected birds with a by collagen. Lactic dehydrogenase was not discharged by dilu- delay in transition of 19s to 7S antibody. Secondary anti- tions greater than 1:10 . Dilutions to 1:100 caused platelet body surge in experimental birds was also significantly (P<.02) lysis and produced characteristic membrane lesions visible in less than controls with continued predominance of 19s antibody.
    [Show full text]
  • Mast Cells in Infection and Immunity†
    INFECTION AND IMMUNITY, Sept. 1997, p. 3501–3508 Vol. 65, No. 9 0019-9567/97/$04.0010 Copyright © 1997, American Society for Microbiology MINIREVIEW Mast Cells in Infection and Immunity† 1,2 2 SOMAN N. ABRAHAM * AND RAVI MALAVIYA Departments of Pathology and Molecular Microbiology, Washington University School of Medicine,1 and Department of Pathology, Barnes-Jewish Hospital of St. Louis,2 St. Louis, Missouri 63110 Mast cells remain one of the most enigmatic cells in the mediates binding of mast cells to parasitic helminths (46). body. These cells secrete significant amounts of numerous Parasitic helminths evoke a specific humoral immune response proinflammatory mediators which contribute to a number of in the host which involves, at least in part, the secretion of a chronic inflammatory conditions, including stress-induced in- large number of IgE antibodies (46). These antibodies become testinal ulceration, rheumatoid arthritis, interstitial cystitis, attached to mast cell surfaces because of the numerous IgE scleroderma, and Crohn’s disease (6, 14, 24, 76). Mast cells are receptors (FcεR) present on mast cell plasma membranes. also prominent in the development of anaphylaxis (14, 24, 76). Those IgE molecules that are specific for helminths then pro- Yet despite the negative effects of their secretions, mast cells mote mast cell binding to the parasite (56). Although IgE is not or mast cell-like cells have been described even among the commonly generated against bacteria, IgE specific to Helico- lowest order of animals (31). The phylogenic persistence of bacter pylori and Staphylococcus aureus has been reported in these cells through evolution strongly suggests that they are patients with peptic ulcers and atopic dermatitis, respectively beneficial in some fashion to the host.
    [Show full text]
  • Innate Immunity
    INNATE IMMUNITY RAKESH SHARDA Department of Veterinary Microbiology NDVSU College of Veterinary Science & A.H., Mhow Innate Immunity - characteristics • Most primitive type of immune system found in virtually all multicellular animals • high discrimination of host and pathogen • First line of defense against infection • no need for prolonged induction • act quickly immediate direct response 0-4 hrs rapid induced 4-96 hrs • antigen-independent Innate Immunity – characteristics (contd.) • dependence on germ line encoded receptors • always present and active, constitutively expressed (some components can be up-regulated) • Nonspecific; not specifically directed against any particular infectious agent or tumor • no clonal expansion of Ag specificity • Same every time; no ‘memory’ as found in the adaptive immune system • failure ==> adaptive immune response Components of Innate Immunity First line Second line 1 Physical barriers A- cells 2 Chemical & biochemical barriers 1- Natural killer 3 Biological barriers (Normal flora) 2- Phagocytes 3- inflammatory cells B- Soluble factors C- Inflammatory barriers Anatomical /Physical/Mechanical Barriers System or Organ Cell type Mechanism Skin Squamous epithelium Physical barrier (intact skin) Desquamation Mucous Membranes Non-ciliated epithelium (e.g. Peristalsis GI tract) Ciliated epithelium, hairs Mucociliary elevator, (e.g. respiratory tract) Coughing, sneezing Epithelium (e.g. Flushing action of nasopharynx) tears, saliva, mucus, urine; blinking of eye lids Biological Factors System or Organ Component
    [Show full text]
  • Superoxide Anion Generation in Human Milk Macrophages: Opsonin-Dependent Versus Opsonin-Independent Stimulation Compared with Blood Monocytes
    0031-3998/01/4903-0435 PEDIATRIC RESEARCH Vol. 49, No. 3, 2001 Copyright © 2001 International Pediatric Research Foundation, Inc. Printed in U.S.A. Superoxide Anion Generation in Human Milk Macrophages: Opsonin-Dependent Versus Opsonin-Independent Stimulation Compared with Blood Monocytes RÜDIGER ADAM, FRANK KUCZERA, HENRIK KÖHLER, AND HORST SCHROTEN Zentrum für Kinderheilkunde, Heinrich-Heine-Universität, 40225 Düsseldorf, Germany ABSTRACT Macrophages are believed to play an important role within the found when unopsonized zymosan was used. After addition of - immunoprotective effects of human breast milk. It was the cytochalasin B, equal inhibition of O2 generation was observed purpose of this study to evaluate the capability of human milk regardless of the cell type or stimulus used. Thus, MM⌽ are ⌽ - macrophages (MM ) to generate superoxide anions (O2 )in stimulated to a greater extent by serum-independent mechanisms comparison with peripheral blood monocytes (BMo) after stim- than BMo. As opsonins like complement or IgG are rare in the ulation with opsonized and unopsonized zymosan. Potential in- colostrum and the neonatal intestinal environment, such a differ- hibitors of attachment and phagocytosis such as mannose and entiation toward serum-independent phagocytic abilities could cytochalasin B were used. Expression of the mannose receptor on play an important role for protective functions of human MM⌽. MM⌽ was demonstrated by staining with MAb. BMo generated Possible involvement of the mannose receptor and the ␤-glucan - ⌽ Ϯ Ϯ - more O2 than MM (417 79 versus 216 15 nmol O2 /mg receptor in this specialization are discussed. (Pediatr Res 49: protein, p Ͻ 0.05) after stimulation with opsonized zymosan.
    [Show full text]
  • 1. Introduction to Immunology Professor Charles Bangham ([email protected])
    MCD Immunology Alexandra Burke-Smith 1. Introduction to Immunology Professor Charles Bangham ([email protected]) 1. Explain the importance of immunology for human health. The immune system What happens when it goes wrong? persistent or fatal infections allergy autoimmune disease transplant rejection What is it for? To identify and eliminate harmful “non-self” microorganisms and harmful substances such as toxins, by distinguishing ‘self’ from ‘non-self’ proteins or by identifying ‘danger’ signals (e.g. from inflammation) The immune system has to strike a balance between clearing the pathogen and causing accidental damage to the host (immunopathology). Basic Principles The innate immune system works rapidly (within minutes) and has broad specificity The adaptive immune system takes longer (days) and has exisite specificity Generation Times and Evolution Bacteria- minutes Viruses- hours Host- years The pathogen replicates and hence evolves millions of times faster than the host, therefore the host relies on a flexible and rapid immune response Out most polymorphic (variable) genes, such as HLA and KIR, are those that control the immune system, and these have been selected for by infectious diseases 2. Outline the basic principles of immune responses and the timescales in which they occur. IFN: Interferon (innate immunity) NK: Natural Killer cells (innate immunity) CTL: Cytotoxic T lymphocytes (acquired immunity) 1 MCD Immunology Alexandra Burke-Smith Innate Immunity Acquired immunity Depends of pre-formed cells and molecules Depends on clonal selection, i.e. growth of T/B cells, release of antibodies selected for antigen specifity Fast (starts in mins/hrs) Slow (starts in days) Limited specifity- pathogen associated, i.e.
    [Show full text]
  • Ch33 WO Pt1.Pdf
    33 Innate Host Resistance 1 33.1 Innate Resistance Overview 1. Identify the major components of the mammalian host immune system 2. Integrate the major immune components and their functions to explain in general terms how the immune system protects the host 2 Host Resistance Overview • Most pathogens (disease causing microbes) – must overcome surface barriers and reach underlying – overcome resistance by host • nonspecific resistance • specific immune response 3 Host Resistance Overview… • Immune system – composed of widely distributed cells, tissues, and organs – recognizes foreign substances or microbes and acts to neutralize or destroy them • Immunity – ability of host to resist a particular disease or infection • Immunology – science concerned with immune responses 4 Immunity • Nonspecific immune response – Aka nonspecific resistance, innate, or natural immunity – acts as a first line of defense – offers resistance to any microbe or foreign material – lacks immunological memory • Specific immune response – Aka acquired, adaptive, or specific immunity – resistance to a particular foreign agent – has “memory” • effectiveness increases on repeated exposure to agent 5 6 Antigens • Recognized as foreign • Invoke immune responses – presence of antigen in body ultimately results in B cell activation production of antibodies • antibodies bind to specific antigens, inactivating or eliminating them • other immune cells also become activated • Name comes from antibody generators 7 White Blood Cells of Innate and Adaptive Immunity • White blood
    [Show full text]
  • Neutrophil Elastase Cleaves C3bi on Opsonized Pseudomonas As Well As CR1 on Neutrophils to Create a Functionally Important Opsonin Receptor Mismatch
    Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. M F Tosi, … , H Zakem, M Berger J Clin Invest. 1990;86(1):300-308. https://doi.org/10.1172/JCI114699. Research Article Neutrophil elastase has been implicated as a factor that impairs local host defenses in chronic Pseudomonas aeruginosa (Pa) lung infection in cystic fibrosis (CF). We recently showed that this enzyme cleaves the C3b receptor, CR1, from neutrophils (PMN) in the lungs of infected CF patients. The C3bi receptor on these cells, CR3, is resistant to elastase. We now show that purified neutrophil elastase markedly impairs complement-mediated PMN-Pa interactions including phagocytosis of opsonized Pa, stimulation by opsonized Pa of PMN superoxide production, and killing of opsonized Pa by PMN. When PMN and opsonized Pa were treated separately with elastase, additive levels of inhibition were observed in each of the above assays. The effects on the bacteria were due to cleavage of the bound C3bi from the surface of opsonized Pa by neutrophil elastase. C3bi was also cleaved by pseudomonas elastase, or bronchoalveolar lavage fluid from CF patients with chronic Pa lung infection. Inhibitors of neutrophil elastase eliminated C3bi cleavage by BAL fluid, while inhibitors of pseudomonas elastase had no effect. Blocking CR1 and CR3 on PMN with specific monoclonal antibodies reduced phagocytosis of opsonized Pa to an extent similar to that caused by elastase cleavage of CR1 on PMN and C3bi on Pa. We conclude that neutrophil elastase in the lungs of chronically infected CF patients cleaves C3bi from opsonized Pa […] Find the latest version: https://jci.me/114699/pdf Neutrophil Elastase Cleaves C3bi on Opsonized Pseudomonas as well as CR1 on Neutrophils to Create a Functionally Important Opsonin Receptor Mismatch Michael F.
    [Show full text]
  • Brief History of Important Immunologic Discoveries and Developments
    Brief History of Important Immunologic Discoveries and Developments Year Event Author(s) 1798 Cowpox vaccination Edward Jenner 1866 Wound disinfection Joseph Lister 1876 Discovery of B. antracis, foundation of Robert Koch bacteriology 1880 Discovery of attenuated vaccine by Louis Pasteur invitro passages 1883 Phagocytosis, cellular immunity theory Elie I. I. Metchnikoff 1888 Discovery of bacterial toxins P. P. Emile Roux and Alexandre E. J. Y ersin 1890 Discovery of antitoxins, foundation of Emil A. von Behring and serotherapy Shibasaburo Kitasato 1894 Immunologic bacteriolysis Richard F. J. Pfeiffer and Vasily I. Isaeff 1894 Discovery of antibody and complement Jules J.B. V. Bordet activity as the active factors in bacteriolysis 1896 Discovery of specific agglutination Herbert E. Durham and Max von Gruber 1896 Agglutination test for the diagnosis of Georges F. I. Widal and typhoid (Widal test) Jean-Marie-Athanase Sicard 1900 Formulation of side-chain theory of anti- Paul Ehrlich body formation 1900 Discovery of A, B, 0 blood groups Karl Landsteiner 1900 Development of complement fixation Jules J.B. V. Bordet and reaction Octave Gengou 1902 Discovery of anaphylaxis Charles R. Richet and Paul Portier 1903 Local anaphylaxis due to antibody- Nicholas M. Arthus antigen complex: Arthus reaction 1903 Discovery of opsonization Almroth E. Wright and Steward R. Douglas 440 Brief History of Important Immunologic Discoveries and Developments Year Event Author(s) 1905 Description of serum sickness Clemens von Pirquet and Bela Schick 1910 Introduction of salvarsan, later neo- Paul Ehrlich and Sahachiro Hata salvarsan, foundation of chemotherapy of infections 1910 Development of anaphylaxis test William Schultz (Schultz-Dale) 1914 Formulation of genetic theory of tumor Clarence C.
    [Show full text]
  • Immunology and Serology
    LECTURE NOTES For Medical Laboratory Technology Students Immunology and Serology Selamawit Debebe Alemaya University In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education 2004 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2004 by Selamawit Debebe All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. Immunology and Serology Preface Immunology and serology is an advanced science dealing with how the human immune system organized, function and the different types of serological techniques. It is a very vast subject covering a wide area of technology.
    [Show full text]
  • Mechanism of Inhibition of Immunoglobulin G-Mediated Phagocytosis by Monoclonal Antibodies That Recognize the Mac- 1 Antigen
    Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac- 1 antigen. E J Brown, … , J F Bohnsack, H D Gresham J Clin Invest. 1988;81(2):365-375. https://doi.org/10.1172/JCI113328. Research Article We have investigated the effects of the monoclonal antibodies against the cell surface molecule Mac-1 on C3bi-mediated rosetting and IgG-mediated rosetting and phagocytosis by human peripheral blood monocytes. Highly purified M1/70 F(ab')2, used in the fluid phase, inhibited both monocyte functions. Half-maximal C3bi rosette inhibition occurred at a concentration of 2 nM F(ab')2 M1/70. An equivalent decrease in IgG-mediated rosetting required 10 nM M1/70 F(ab')2, and 50% inhibition of IgG-mediated phagocytosis required 7 nM antibody. Mo-1 F(ab')2 inhibited EC3bi binding with an ID50 of 0.3 nM, whereas 50% decrease in IgG-mediated rosetting required 70 nM of this antibody. OKM1 did not inhibit rosettes of sheep erythrocytes opsonized with IgG antibody (EA) at all. F(ab')2 M1/70 did not affect the binding of monomeric human IgG to monocytes, but did substantially decrease the binding of IgG aggregates. Half-maximal inhibition of aggregated IgG binding at 0 degrees C occurred at 8 nM F(ab')2 M1/70, very close to the concentration that caused equivalent inhibition of IgG-mediated phagocytosis. Aggregated IgG inhibited the binding of radiolabeled M1/70 to monocytes by approximately 40%, suggesting that some, but not all Mac-1 molecules were associated with IgG receptors under these conditions.
    [Show full text]